Categories AlphaGraphs, Earnings, Energy

XOM Earnings: ExxonMobil reports record profit for Q2 amid 71% revenue growth

ExxonMobil Corporation (NYSE: XOM) reported a record profit for the second quarter of 2022 as the energy giant’s revenues surged. The headline numbers also surpassed the market’s projection. The company’s stock made strong gains early Friday, following the announcement.

ExxonMobil Q2 2022 earnings infographic

Net profit, adjusted for special items, climbed to $4.14 per share during the three-month period from $1.10 per share a year earlier. Analysts were looking for a smaller number for the latest quarter. On a reported basis, the company posted a net income of $17.9 billion or $4.21 per share, compared to $4.7 billion or $1.10 per share in the second quarter of 2021.

Driving the bottom-line growth, total revenues and other income jumped to $115.7 billion in the June quarter from $67.7 billion in the same period of last year. The latest number also topped Wall Street’s expectations.


Check this space to read management/analysts’ comments on ExxonMobil’s Q2 2022 results


“Earnings and cash flow benefited from increased production, higher realizations, and tight cost control. Strong second-quarter results reflect our focus on the fundamentals and the investments we put in motion several years ago and sustained through the depths of the pandemic,” said Darren Woods, chief executive officer of ExxonMobil.

Prior Performance

  • ExxonMobil Q1 2022 earnings infographic
  • ExxonMobil Q2 2021 earnings infographic

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top